. .
Bruker Daltonics
Bruker
Search

Search for literature

Login here!

Please state your username and your password below, in order to login to our user-system.

Bruker BioSciences Corporation Files Definitive Proxy with the SEC, Including Proposals for Acquisition of Bruker Optics

. May 2006

admin

BILLERICA, Mass.--(BUSINESS WIRE)--May 25, 2006--

Bruker BioSciences Corporation (Nasdaq: BRKR) announced today that it has filed a definitive proxy statement with the Securities and Exchange Commission for its annual meeting of shareholders, which includes proposals relating to shareholder approval of its proposed acquisition of Bruker Optics Inc.




ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR)



Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading developer and provider of life science, materials research, and industrial X-ray analysis tools. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. For more information, please visit www.bruker-biosciences.com.



CONTACT:

Bruker BioSciences Corporation

Michael Willett, 978-663-3660, ext. 1411

Michael.Willett@bruker.com



SOURCE:

Bruker BioSciences Corporation

 
think forward